ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Names Director Of New Center For Tobacco Products

September 11, 2009

NCI Establishes New Program Project Grant Guidelines.

January 13, 2006

Guest Editorial : Why I Don’t Want to Pay for Your Horoscope: Reflections on FDA Warning to 23 and Me

December 13, 2013

Flood Mistrial

February 9, 1979

Bills Introduced On Breast Cancer Screening, DES, Cigarette Tax Hike

January 30, 1987

In Brief: Olden Chosen To Head NIEHS; Cancer Panel To Discuss Cancer and Poverty On July 9

June 28, 1991